[Asia Economy Reporter Ji Yeon-jin] Alteogen announced on the 16th that the Ministry of Food and Drug Safety approved the Phase 1 clinical trial plan to evaluate the safety, tolerability, and pharmacokinetic characteristics of 'ALT-BB4 (Terzyme, recombinant hyaluronidase)' in healthy adults.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
